Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.
about
Cyclosporin versus tacrolimus for liver transplanted patientsCyclosporin versus tacrolimus for liver transplanted patientsTacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipientsRenal transplantationInterleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial dataControversies in the treatment of idiopathic membranous nephropathy.New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.Belatacept: a new biologic and its role in kidney transplantation.Sirolimus is associated with new-onset diabetes in kidney transplant recipients.Recent developments in the pharmacological treatment and prevention of corneal graft rejection.Tacrolimus immunosuppression in high-risk corneal grafts.What is the calcineurin inhibitor of choice for pediatric renal transplantation?Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitisPilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantationTrends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects.The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.A limited sampling strategy for tacrolimus in renal transplant patientsCalcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort studyTacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.Pharmacotherapy of corneal transplantation.Tacrolimus in transplant rejection.Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.Advances in pharmacotherapy to treat kidney transplant rejection.Interaction Study of an Amorphous Solid Dispersion of Cyclosporin A in Poly-Alpha-Cyclodextrin with Model Membranes by (1)H-, (2)H-, (31)P-NMR and Electron Spin Resonance.The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization.Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies.Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring.Antibody induction therapy in adult kidney transplantation: A controversy continues.Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation?Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients.Action of tacrolimus on Wistar rat kidneys implanted with Walker 256 carcinosarcoma.
P2860
Q24244114-8C099137-1492-421C-BBD9-3BB141C0AD0BQ24245303-EFADB751-6BD1-4EB2-BD17-B7B7235A2581Q24245456-DDDEF684-EEC3-438B-8599-77C610C06386Q28769695-BF80A087-0DCA-431D-8143-F855B0AF6E84Q30725010-35978610-CC0B-493A-B741-ABAD67733BE7Q30996903-C4D44ACD-B6B6-4782-99A0-2A89324C328BQ31004418-EA9F78F3-AA0B-4BC1-8315-D373F185CDAEQ34248343-528FD641-689E-44D0-9115-84ED833F279BQ34368857-43B1E0E9-930D-4C67-908E-0B5BB5EDBCADQ34634807-AA598C68-612C-429E-B001-FD150A0D2BEDQ34767143-6CD9AF0B-87B3-4C18-8644-13CFB8AF3020Q35040789-DCB9F2AA-0C7F-488A-8C26-806C06A56FEFQ35762878-A0F8FC3B-4E37-46E7-ABBF-D9E0CE571646Q35887516-6E73B29A-A816-4140-9E58-4F7C4F7A74B1Q36073213-591019A8-9FFC-4DD9-BB19-2CBB94EEFC5CQ36128203-7231EA31-235A-48DE-B134-67C8442F47DFQ36340692-B7096FE7-DBD3-4028-93C4-69DE1FFC6E0EQ36423616-22FD7C8B-2308-4540-B7B0-DC5E35DAD68AQ36530398-7C2CA61C-7B4B-462E-B371-8C3BDC959545Q36742537-98CD391C-564C-4E78-8399-4BF660C973DCQ36742552-8EC8C173-E557-471C-85C7-E41963F2D9CDQ36922261-EA5DF4BE-1F62-40C3-88A8-56FFD016DC00Q37199764-77E4B2BD-9606-4869-B1FB-02022E8AB64FQ37271349-F83F9AA5-60FB-495A-AB04-576EDB70875FQ37522597-B022B01A-1169-4B0D-9DCB-5D32A2BE8DFFQ37838123-82C13C37-8F7D-4FF7-B17F-5AB91707C1F3Q37994335-D4B9EBF6-2C52-4B2E-9FE5-537FE9DE3C40Q38066267-D04298DA-C5AC-4440-ABF5-7941AC4801A7Q38534443-7DE51768-C03D-4EC3-96F0-2246809944BCQ38544529-388F8E5B-A1B5-4C3C-BA2F-A7F046EBE7CBQ39766247-D5C3C722-3F55-42A0-AFA6-B3C40FFA7BEAQ39961876-D75181A9-A19C-4103-BAA7-78CFEB83BB36Q40709377-7C6D19FE-4D41-4041-9397-5D68C6069B32Q41957755-A83CE9D6-D6E2-4A4E-993B-92A555905494Q42242119-33AA62BD-F10D-4AC2-897B-0D40C5CBE65AQ42948459-A5D2DDD9-8CDB-457E-866F-D09CAD3621ADQ42969608-C75979FC-F87E-40F9-B9EA-7EB43E895BE1Q43034760-626940C0-0786-4124-ADA8-922C82A0E78AQ43133854-0631A16D-1961-4116-A857-8A012B7B0D8AQ43176588-F76979D5-F476-46E3-B360-0F9F3604721D
P2860
Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@en
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@nl
type
label
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@en
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@nl
prefLabel
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@en
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@nl
P2860
P1433
P1476
Tacrolimus versus cyclosporin ...... analysis of randomised trials.
@en
P2093
P2860
P304
P356
10.1136/BMJ.318.7191.1104
P407
P577
1999-04-01T00:00:00Z